Healthcare
Live Price
Offline$156.78
+2.04% today
1Y Change
+1.94%
Window
Jun 26, 2025 โ Jun 22, 2026
Coverage: 247 bars ยท Jun 26, 2025 โ Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
The Ensign Group, Inc. (ENSG) is a Healthcare stock with a market cap of $10.28B and listed on NASDAQ. The stock last traded around $156.78 and up 1.9% across the available one-year price window (Jun 26, 2025 โ Jun 22, 2026). Baseline metrics include revenue growth of +18.7%, EPS growth of +14.1%, a dividend yield of 0.1%. What stands out right now is revenue +18.7%, EPS +14.1%, free cash flow +96.2% with operating margin 8.5% and ROIC 7.0%. The dividend is present but secondary, with a yield around 0.1%. Valuation is more restrained than many high-expectation growth names at P/E 28.0 and price/sales 1.9. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines ENSG price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+18.7% vs +7.6% peer median
Operating Margin
Below sector median
+8.5% vs +19.4% peer median
P/E
Below sector median
28.0 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 5, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +18.7% and EPS at +14.1%, with operating margin around 8.5%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 0.1%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +7.0% over the next 5 trading days and finished higher after 2 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 5, 2026 | โ | -0.0% | +0.1% | -5.3% |
2026 Feb 4, 2026 | +4.0% | +13.8% | +22.4% | +19.7% |
2025 Nov 3, 2025 | +3.1% | +0.1% | -1.3% | -1.5% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
ENSG
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
ENSG Max Drawdown
-31.83%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for ENSG and SPY.

Company Overview
The Ensign Group, Inc.
NASDAQ Global Select
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.